BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

616 related articles for article (PubMed ID: 36521737)

  • 1. Regulation of epithelial-mesenchymal transition by tumor microenvironmental signals and its implication in cancer therapeutics.
    Zhang J; Hu Z; Horta CA; Yang J
    Semin Cancer Biol; 2023 Jan; 88():46-66. PubMed ID: 36521737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular pathways: linking tumor microenvironment to epithelial-mesenchymal transition in metastasis.
    Jung HY; Fattet L; Yang J
    Clin Cancer Res; 2015 Mar; 21(5):962-968. PubMed ID: 25107915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of genetic and microenvironmental factors in cancer epithelial-to-mesenchymal transition and therapeutic implication.
    Yang L; Shang Z; Long S; Wang N; Shan G; Zhang R
    Exp Cell Res; 2018 Sep; 370(2):190-197. PubMed ID: 30075173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The tumor microenvironment: An irreplaceable element of tumor budding and epithelial-mesenchymal transition-mediated cancer metastasis.
    Li H; Xu F; Li S; Zhong A; Meng X; Lai M
    Cell Adh Migr; 2016 Jul; 10(4):434-46. PubMed ID: 26743180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor microenvironment and noncoding RNAs as co-drivers of epithelial-mesenchymal transition and cancer metastasis.
    Drak Alsibai K; Meseure D
    Dev Dyn; 2018 Mar; 247(3):405-431. PubMed ID: 28691356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic EMT: a multi-tool for tumor progression.
    Brabletz S; Schuhwerk H; Brabletz T; Stemmler MP
    EMBO J; 2021 Sep; 40(18):e108647. PubMed ID: 34459003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia-induced epithelial to mesenchymal transition in cancer.
    Hapke RY; Haake SM
    Cancer Lett; 2020 Sep; 487():10-20. PubMed ID: 32470488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix Rigidity Controls Epithelial-Mesenchymal Plasticity and Tumor Metastasis via a Mechanoresponsive EPHA2/LYN Complex.
    Fattet L; Jung HY; Matsumoto MW; Aubol BE; Kumar A; Adams JA; Chen AC; Sah RL; Engler AJ; Pasquale EB; Yang J
    Dev Cell; 2020 Aug; 54(3):302-316.e7. PubMed ID: 32574556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic and microenvironmental heterogeneity shaping epithelial-to-mesenchymal trajectories in cancer.
    Malagoli Tagliazucchi G; Wiecek AJ; Withnell E; Secrier M
    Nat Commun; 2023 Feb; 14(1):789. PubMed ID: 36774358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosome-Associated circRNAs as Key Regulators of EMT in Cancer.
    Amicone L; Marchetti A; Cicchini C
    Cells; 2022 May; 11(10):. PubMed ID: 35626752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-652 inhibits acidic microenvironment-induced epithelial-mesenchymal transition of pancreatic cancer cells by targeting ZEB1.
    Deng S; Li X; Niu Y; Zhu S; Jin Y; Deng S; Chen J; Liu Y; He C; Yin T; Yang Z; Tao J; Xiong J; Wu H; Wang C; Zhao G
    Oncotarget; 2015 Nov; 6(37):39661-75. PubMed ID: 26498682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EMT Transition States during Tumor Progression and Metastasis.
    Pastushenko I; Blanpain C
    Trends Cell Biol; 2019 Mar; 29(3):212-226. PubMed ID: 30594349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer-associated fibroblasts are the main contributors to epithelial-to-mesenchymal signatures in the tumor microenvironment.
    Szabo PM; Vajdi A; Kumar N; Tolstorukov MY; Chen BJ; Edwards R; Ligon KL; Chasalow SD; Chow KH; Shetty A; Bolisetty M; Holloway JL; Golhar R; Kidd BA; Hull PA; Houser J; Vlach L; Siemers NO; Saha S
    Sci Rep; 2023 Feb; 13(1):3051. PubMed ID: 36810872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Collagen-rich stroma in aggressive colon tumors induces mesenchymal gene expression and tumor cell invasion.
    Vellinga TT; den Uil S; Rinkes IH; Marvin D; Ponsioen B; Alvarez-Varela A; Fatrai S; Scheele C; Zwijnenburg DA; Snippert H; Vermeulen L; Medema JP; Stockmann HB; Koster J; Fijneman RJ; de Rooij J; Kranenburg O
    Oncogene; 2016 Oct; 35(40):5263-5271. PubMed ID: 26996663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interplay of Immunometabolism and Epithelial-Mesenchymal Transition in the Tumor Microenvironment.
    Chou MY; Yang MH
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-associated macrophages and epithelial-mesenchymal transition in cancer: Nanotechnology comes into view.
    Vakili-Ghartavol R; Mombeiny R; Salmaninejad A; Sorkhabadi SMR; Faridi-Majidi R; Jaafari MR; Mirzaei H
    J Cell Physiol; 2018 Dec; 233(12):9223-9236. PubMed ID: 30078227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simulation of multiple microenvironments shows a pivot role of RPTPs on the control of Epithelial-to-Mesenchymal Transition.
    Pais RJ
    Biosystems; 2020 Dec; 198():104268. PubMed ID: 33068671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer.
    Du B; Shim JS
    Molecules; 2016 Jul; 21(7):. PubMed ID: 27455225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Mechanisms of Epithelial to Mesenchymal Transition Regulated by ERK5 Signaling.
    Bhatt AB; Patel S; Matossian MD; Ucar DA; Miele L; Burow ME; Flaherty PT; Cavanaugh JE
    Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33572742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hybrid Epithelial-Mesenchymal Phenotypes Are Controlled by Microenvironmental Factors.
    Selvaggio G; Canato S; Pawar A; Monteiro PT; Guerreiro PS; BrĂ¡s MM; Janody F; Chaouiya C
    Cancer Res; 2020 Jun; 80(11):2407-2420. PubMed ID: 32217696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.